June 25, 2014, Wixom, Michigan
SentioMMG® recognized by Crain’s Detroit Business for its intellectual property portfolio
Sentio, LLC, of Wixom, Michigan, announced today that it had been recognized by Crain’s Detroit Business (Crain Communications, Inc.) as having one of Michigan’s top intellectual property portfolios. This recognition emphasizes the substantial creative and intellectual investment Sentio has made in surgical applications of its revolutionary mechanomyography sensor technology.
Chris Wybo, President of Sentio, said on Thursday, “ This recognition truly resonates with the Sentio team– we pride ourselves on leveraging this unique technology into practical surgical applications, delivering useful information regarding nerve location and identification in an easy to use system. The work of the our team represents decades of cumulative effort to bring us to this point.” He went on to say how helpful this has been in creating an understanding of the market value of IP. “We know the work we do is valuable; the Eureka Index and Ocean Tomo rating system helps quantify that value through an objective evaluation of dozens of criteria around Sentio’s IP portfolio, putting it into a market context.”
“As we expand our global market presence, this recognition lends substantial credibility for our technology. This has great potential value for current and future hardware partners working with Sentio” stated Sean Parker, Vice President, Market Development.
Sentio is currently cleared for use by the FDA to assist in locating and mapping motor nerves through the use of mechanomyographic signals and electrical stimulus of nerves. It is indicated for locating and identifying spinal nerve roots and peripheral motor nerves originating from spinal levels C3-T1 and L2-S2. SentioMMG has a CE mark for use in EU and other markets.
SENTIO, LLC is a technology-driven medical device company, specializing in the development and manufacturing of proprietary nerve mapping systems. Injury to nerves is a major risk of surgical procedures and protection of nerves becomes an increasing challenge with minimally invasive surgery (MIS). Sentio has pioneered a game changing method for mapping nerve location, resulting in improved technology for surgeons to use as compared to traditional techniques.